País: Singapur
Idioma: anglès
Font: HSA (Health Sciences Authority)
Interferon beta-1a
MERCK PTE. LTD.
L03AB07
44 mcg/0.5mL
INJECTION, SOLUTION
SUBCUTANEOUS
Prescription Only
Merck Serono S.A.
2014-03-13
1. NAME OF THE MEDICINAL PRODUCT Rebif 44 micrograms solution for injection in pre-filled pen 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each Rebif 44 micrograms solution for injection in pre-filled pen contains 44 micrograms (12 MIU*) of interferon beta-1a** in 0.5 ml solution. * Million International Units, measured by cytopathic effect (CPE) bioassay against the in-house IFN beta-1a standard which is calibrated against the current international NIH standard (GB-23-902-531). ** produced in Chinese hamster ovary Cells (CHO-K1) by recombinant DNA technology. Excipient: 2.5 mg benzyl alcohol For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection in pre-filled pen. Clear to opalescent solution, with pH 3.5 to 4.5 and osmolarity 250 to 450 mOsm/l. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Rebif is indicated for the treatment of x patients with a single demyelinating event with an active inflammatory process, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing relapsing multiple sclerosis (see section 5.1) x patients with relapsing multiple sclerosis. In clinical trials, this was characterised by two or more acute exacerbations in the previous two years (see section 5.1). Efficacy has not been demonstrated in patients with secondary progressive multiple sclerosis without ongoing relapse activity (see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Treatment should be initiated under supervision of a physician experienced in the treatment of the disease. Rebif is available in two strengths: 22mcg and 44mcg. When first starting treatment with Rebif, in order to allow tachyphylaxis to develop thus reducing adverse reactions it is recommended that patients be started at 8.8 micrograms dose subcutaneously and the dose be increased over Llegiu el document complet